The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Vacirca elected COA president

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Jeffrey Vacirca was elected president of the Community Oncology Alliance for a one year term starting Jan. 1.

Vacirca is the CEO and managing partner/director of clinical research at New York Cancer Specialists in Long Island, NY.

In addition to Vacirca, new executive committee officers and members of the board of directors were elected.

A complete and updated list of Officers and Board members can be viewed here.

Table of Contents

YOU MAY BE INTERESTED IN

AACR Cancer Progress Report makes the case for federal investment in cancer research

As NCI and NIH funding is being deliberated in Congress, this year’s 2025 AACR Cancer Progress Report had an unequivocal message: With 20 new anticancer therapeutics, new uses for eight previously approved anticancer therapeutics, two new early detection tools, and several AI-powered diagnostics approved over the span of just one year, cancer research funding yields a good return on investment. 
By Sara Willa Ernst
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account